[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $lctx

Social media buzz around $lctx highlights potential gene therapy business models, with a top post discussing CRISPR companies and Eli Lilly's gene editing assets. The discussion touches on licensing models for genetic treatments, indicating active conversation within the biotech and crypto space.

### About $lctx
$lctx is a cryptocurrency project focused on cell therapy treatments.  

### Insights
- $lctx mentions near a 52-week low at X.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$lctx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$lctx/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX +28%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXXXX +110%  
1-Year High: XXXXXXX on 2025-03-10  
1-Year Low: XX on 2025-01-28  

Engagements by network (24h):
X: XXX

  
  
### Mentions: X (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$lctx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$lctx/time-series/posts_active.tsv)  
Current Value: X  
Daily Average: XX  
X Week: XXX -XXXX%  
X Month: XXX +138%  
X Months: XXXXX +207%  
X Year: XXXXX +668%  
1-Year High: XXX on 2025-06-30  
1-Year Low: X on 2025-01-27  

Mentions by network (24h):
X: X

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$lctx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$lctx/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $lctx in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX  
X Week: XX no change  
X Month: XXX +160%  
X Months: XXX +367%  
X Year: XXXXX +659%  
1-Year High: XXX on 2025-06-30  
1-Year Low: X on 2025-10-26  

The most influential creators that mention $lctx in the last XX hours

| Creator                                      | Rank | Followers | Posts | Engagements |
| -------                                      | ---- | --------- | ----- | ----------- |
| [@barton70357](/creator/twitter/barton70357) | X    | XX        | X     | X           |

[View More](/list/creators/$lctx/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$lctx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$lctx/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% no change  
X Year: XX% no change  
1-Year High: XXX% on 2024-12-09  
1-Year Low: XX% on 2024-12-27  

Most Supportive Themes:
- OpRegen Cell Therapy: (60%) Lineage Cell Therapeutics is advancing its OpRegen treatment for retinal diseases, showing positive Phase X data and moving towards Phase X trials.
- Off-the-Shelf Solutions: (30%) There is rising support for 'off-the-shelf' cell therapy solutions, particularly in non-oncology indications.
  
Most Critical Themes:
  

### Top $lctx Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Here is an excellent answer for a question which Im asked a lot - could there be a viable business model for a one & done Gene Therapy treatment and for CRISPR companies such as $PRME $BEAM $NTLA $CRSP $CRBU $MGX $LCTX $SANA and more. During his excellent conversation with Stripes co-founder John collision in the Cheeky Pint podcast Dave Ricks - Eli Lillys CEO described $LLY recent Gene Editing asset - $VERV-102 which was acquired by Lilly as part of the Verve Theraputics acquisition 🧵👇 and also presented a new and interesting business model - a multi-year licensing model for genetic"  
[X Link](https://x.com/yaireinhorn/status/1993656480172556725) [@yaireinhorn](/creator/x/yaireinhorn) 2025-11-26T12:21Z 17.7K followers, 28.4K engagements